KDNY

Chinook Therapeutics, Inc. Common Stock
KDNY

Overview Fund Activity
Delisted

KDNY was delisted on the 10th of August, 2023.

Back to rankings

155 hedge funds and large institutions have $1.49B invested in Chinook Therapeutics, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 58 increasing their positions, 46 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
155
Holders Change
+4
Holders Change %
+2.65%
% of All Funds
2.5%
Holding in Top 10
8
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+33.33%
% of All Funds
0.13%
New
22
Increased
58
Reduced
46
Closed
18
Calls
$969K
Puts
$316K
Net Calls
+$653K
Net Calls Change
-$9.2M

Top Buyers

1
Federated Hermes
1
Federated Hermes
Pennsylvania
$23.3M
2
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$21.5M
3
SI
3
Sofinnova Investments
California
$21.1M
4
PAMS
4
Pictet Asset Management (Switzerland)
Switzerland
$30.6M
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$73.2M

Top Sellers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$33.2M
2
Assenagon Asset Management
2
Assenagon Asset Management
Luxembourg
$23.3M
3
SFM
3
Sphera Funds Management
Israel
$3.33M
4
RCMNY
4
Rubric Capital Management (New York)
New York
$18.9M
5
HM
5
HealthCor Management
New York
$1.57M
Name Holding Trade Value Shares
Change 		Shares
Change %
EC
26
EcoR1 Capital
California
$18.1M – – –
NIP
27
Nicholas Investment Partners
California
$16.8M +$1.97M +75,305 +13%
Northern Trust
28
Northern Trust
Illinois
$14M +$2.93M +111,777 +26%
Citadel Advisors
29
Citadel Advisors
Florida
$13.4M +$7.6M +290,148 +131%
RSCM
30
Rock Springs Capital Management
Maryland
$13.3M – – –
Baillie Gifford & Co
31
Baillie Gifford & Co
United Kingdom
$12.8M +$665K +25,394 +5%
Millennium Management
32
Millennium Management
New York
$11.5M +$1.09M +41,769 +10%
ACM
33
Altium Capital Management
New York
$10.1M -$3.67M -140,000 -27%
Charles Schwab
34
Charles Schwab
California
$10.1M +$242K +9,225 +2%
EAM
35
Eventide Asset Management
Massachusetts
$9.66M +$9.66M +368,811 New
Ensign Peak Advisors
36
Ensign Peak Advisors
Utah
$9.48M +$3.27M +124,933 +53%
D.E. Shaw & Co
37
D.E. Shaw & Co
New York
$9.43M -$3.14M -119,742 -25%
IBT
38
International Biotechnology Trust
United Kingdom
$8.91M – – –
EAM
39
Erste Asset Management
Austria
$8.06M – – –
Fidelity Investments
40
Fidelity Investments
Massachusetts
$8.04M -$588K -22,429 -7%
Morgan Stanley
41
Morgan Stanley
New York
$7.39M -$90.3K -3,447 -1%
SVCM
42
Saturn V Capital Management
Texas
$6.73M +$6.73M +423,177 New
Two Sigma Advisers
43
Two Sigma Advisers
New York
$6.21M -$215K -8,200 -3%
Connor, Clark & Lunn Investment Management (CC&L)
44
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$6.18M -$1.35M -51,468 -18%
Bank of New York Mellon
45
Bank of New York Mellon
New York
$5.79M +$277K +10,567 +5%
Goldman Sachs
46
Goldman Sachs
New York
$5.56M -$4.99M -190,414 -47%
Invesco
47
Invesco
Georgia
$5.46M +$352K +13,422 +7%
PI
48
Putnam Investments
Massachusetts
$4.8M -$189K -7,200 -4%
Renaissance Technologies
49
Renaissance Technologies
New York
$4.76M -$987K -37,680 -17%
Bank of America
50
Bank of America
North Carolina
$4.59M +$941K +35,910 +26%
1
2
3 4 5